AEGiS-UNAIDS: Increased HIV services for drug users needed UNAIDSImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Click here to return to UNAIDS main menu
DonateNow
Print this Article


Increased HIV services for drug users needed

UNAIDS Press Release - November 14, 2006


Increasing access to HIV prevention, treatment, care and support services for drug users and their partners is crucial to addressing the issue of growing HIV infections related to injecting drug use in the Middle East and North Africa region.

This was the overwhelming conclusion reached by regional representatives from law enforcement agencies, national AIDS programmes, NGOs, researchers, community representatives, people living with HIV and UN organizations who joined at a regional workshop on the issue of HIV and drug use in the region, held in Cairo, Egypt from 5 - 8 November.

Throughout the 3-day discussions, participants from the Arab countries, Afghanistan, Iran and Pakistan affirmed that drug use is an important risk factor in facilitating spread of HIV that calls for immediate action. Joint efforts of police, national AIDS actors, NGOs, drug users and of people living with HIV were recognized as fundamental elements in the prevention of HIV among drug users and their partners.

While significant efforts are being undertaken in a number of countries to reach out with HIV preventive services to drug users communities, limited capacities coupled with discrimination against drug users hamper implementation of wider-scale programmes.

"From my personal experience and my field work on reducing harm related to drug use, I suggest training more drug users and ex-drug users -to build their skills in order to promote and implement [HIV preventive] programs in the region," an ex-drug user and outreach worker said in the workshop.

New initiatives for building capacities of civil society actors on implementing harm reduction measures and networking in the region were discussed and examined.

"Participation in this workshop has allowed an exchange of international experiences among NGOs and governments, and a discussion of the strategic approaches to planning at the national level to protect against the harms and risks of drugs and related HIV. It has created cooperation between [national stakeholders]...and encouraged civil society actors to assist and support alternative programs for drug users," police participants from one of the Gulf countries said.

As part of the workshop, UNAIDS and UNODC launched the finalized Rapid Situation Assessment on Drug Use and HIV in Algeria and Morocco, as well as facilitate consensus on programmatic follow up for all participating countries. WHO and the International Harm Reduction Association launched a project on strengthening the role of civil society in harm reduction for injecting drug users in the Middle East and North Africa.

Although the main mode of HIV transmission in the Middle East and North Africa remains unprotected sexual contact, injecting drug use is an increasingly important factor in the region's epidemics.


061114
UN061106


Copyright © 2006 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .